Literature DB >> 9227549

Hypercholesterolemia is associated with enhanced angiotensin AT1-receptor expression.

G Nickenig1, O Jung, K Strehlow, O Zolk, W Linz, B A Schölkens, M Böhm.   

Abstract

Low-density lipoprotein increases the AT1-receptor gene expression in vascular smooth muscle cells. To elucidate whether elevated cholesterol serum levels upregulate the AT1 receptor and its functional response to angiotensin II in vivo, we compared 1) the vasoconstrictive effect of angiotensin II and 2) the level of expression of the vascular AT1 receptor in aortas of normocholesterolemic and hypercholesterolemic rabbits. Contraction experiments on isolated aortic rings showed that the angiotensin II-induced vasoconstriction was increased in hypercholesterolemic New Zealand White rabbits compared with normocholesterolemic New Zealand White rabbits. This difference in the angiotensin II-induced vasoconstriction was caused by a twofold increase in the density of cell surface AT1 receptors in hypercholesterolemic rabbits, as assessed by radioligand binding assays. The enhanced expression of AT1 receptors on the surface of these vascular cells was caused by elevated steady-state levels of the AT1-receptor mRNA to 220 +/- 35% in aortas excised from hypercholesterolemic rabbits compared with levels in aortas from normocholesterolemic rabbits, as measured by Northern blot analysis. These data indicate that hypercholesterolemia is associated with upregulation of expression and function of vascular AT1 receptors in vivo. This suggests a novel mechanism by which hypercholesterolemia could be involved in the onset and progression of chronic vascular diseases such as hypertension and arteriosclerosis if the phenomenon is confirmed in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9227549     DOI: 10.1152/ajpheart.1997.272.6.H2701

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  29 in total

1.  Interaction between blood pressure, lipoproteins, angiotensin, and vascular disease.

Authors:  Aram V Chobanian
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

2.  Angiotensin II induces the aggregation of native and oxidized low-density lipoprotein.

Authors:  Akira Sato; Chiemi Ueda; Ryu Kimura; Chisato Kobayashi; Yoji Yamazaki; Keiichi Ebina
Journal:  Eur Biophys J       Date:  2017-04-11       Impact factor: 1.733

3.  Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.

Authors:  K M Yee; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 4.  Understanding the Two Faces of Low-Salt Intake.

Authors:  Branko Braam; Xiaohua Huang; William A Cupples; Shereen M Hamza
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

Review 5.  Hypertension and lipids: lipid factors in the hypertension syndrome.

Authors:  Gary E Sander; Thomas D Giles
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

6.  Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice.

Authors:  Haruhito A Uchida; Fjoralba Kristo; Debra L Rateri; Hong Lu; Richard Charnigo; Lisa A Cassis; Alan Daugherty
Journal:  Atherosclerosis       Date:  2010-03-04       Impact factor: 5.162

7.  The role of type 1 angiotensin receptors on T lymphocytes in cardiovascular and renal diseases.

Authors:  Jiandong Zhang; Steven D Crowley
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

8.  Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.

Authors:  Sean E Thatcher; Xuan Zhang; Deborah A Howatt; Hong Lu; Susan B Gurley; Alan Daugherty; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-20       Impact factor: 8.311

9.  Interaction of angiotensin-converting enzyme and apolipoprotein E gene polymorphisms in ischemic stroke involving large-vessel disease.

Authors:  Sarra Saidi; Walid Zammiti; Lamia B Slamia; Sofyan B Ammou; Wassim Y Almawi; Touhami Mahjoub
Journal:  J Thromb Thrombolysis       Date:  2007-11-21       Impact factor: 2.300

10.  Characteristic changes in coronary artery at the early hyperglycaemic stage in a rat type 2 diabetes model and the effects of pravastatin.

Authors:  J Kajikuri; Y Watanabe; Y Ito; R Ito; T Yamamoto; T Itoh
Journal:  Br J Pharmacol       Date:  2009-07-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.